Company / Depreciation & Amortization
Solid Biosciences Inc. Depreciation & Amortization History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$3.9M
FY2022
5-year range
$56.0K / $3.9M
FY2018-FY2022
Trend
+38.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has increased for 4 consecutive years, from $56,000 in FY2018 to $4M in FY2022.
Based on SEC 10-K filings.
$4M in FY2022 with a 3-year CAGR of +106.1%.
Increased from $2M to $4M over the past 2 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +106.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Solid Biosciences Inc.'s depreciation & amortization has grown for 4 consecutive years.
- 3-year CAGR of +106.1%, indicating consistent growth.
- In FY2022, depreciation & amortization increased 38.9% year-over-year.
- Lowest depreciation & amortization in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $3.9M | +38.9% |
| FY2021 | $2.8M | +80.3% |
| FY2020 | $1.6M | +249.6% |
| FY2019 | $448.0K | +700.0% |
| FY2018 | $56.0K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026